- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04047524
A Trimodal Prehabilitation Study for Patients Undergoing Major Abdominal Surgery
16. august 2019 opdateret af: Shira Baram
Trimodal Prehabilitation Programme Using Smart Watches and Mobile Applications in Patients Undergoing Major Abdominal Surgery: a Randomised Controlled Pilot Study
Prehabilitation programmes have the potential to reduce post-operative complications following abdominal cancer surgery by improving pre-operative fitness levels.
Home-based prehabilitation programmes may be more cost effective than hospital-based programmes, but have issues with low compliance.
The aims of our study are to assess whether mobile technologies such as smart watches and smartphone applications improve compliance with home-based prehabilitation programmes and to assess the effects of prehabilitation on pre-operative fitness levels in patients due to undergo major abdominal cancer surgery.
Studieoversigt
Status
Ukendt
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
30 patients due to undergo major abdominal cancer surgery at The Christie NHS Foundation Trust will be enrolled to a pilot randomised controlled trial.
They will randomised to either a home-based trimodal prehabilitation programme, delivered by the use of FitBit Smart Watches and Smartphone applications, or a control group who will receive a FitBit for physical activity monitoring only, for a period of 2-6 weeks prior to surgery.
The prehabilitation programme will include exercise, nutritional, and psychological components.
Study outcomes will include 6MWT (6-minute walk test), HADS (hospital anxiety and depression score), steps per day, length of stay post-operatively, and post-operative complications.
Undersøgelsestype
Interventionel
Tilmelding (Forventet)
30
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
-
Manchester, Det Forenede Kongerige
- Rekruttering
- The Christie NHS Foundation Trust
-
Kontakt:
- Shira Baram
- Telefonnummer: 01619182098
- E-mail: shira.baram@christie.nhs.uk
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år til 80 år (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- be aged 18 years or over
- be able to consent to participate in the prehabilitation programme
- be undergoing major abdominal cancer surgery (including, but not limited to, cytoreductive surgery with hyperthermic intraperitoneal chemotherapy)
- have at least 2 weeks to their operation date
- be able to understand written and spoken English
Exclusion Criteria:
- patients have any health conditions which will prevent them from safely taking part in a home-based exercise programme. For example, but not limited to, patients who have recently (within the past 3 months) had a myocardial infarction or a stroke or patients who have end-stage renal disease but are not on dialysis. We will use the "Safety Reference Guide to support exercise services in people with cancer" in The Lancet published paper "Exercise as part of routine cancer care"(5) to aid the screening of patients suitability.
- they have any bone metastasis
- are already active users of a FitBit device
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Grundvidenskab
- Tildeling: Randomiseret
- Interventionel model: Sekventiel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Andet: Prehabilitation
These participants will receive a home based prehabilitation programme for a period of 2-6 weeks prior to surgery and will be provided with a Fitbit Charge 2.
|
Each participant will receive a Fitbit.
The Prehabilitaiton Group will receive a Fitbit Charge 2 and they will be able to review their progress on this and be required to increase their exercise activity and input information and data about the exercise they have completed each day during their participation in the study.
The Control group will receive a Fitbit Flex and will not be required to review any of their activity or input any data and will be encouraged to continue with their daily activity rates i.e. not to change.
|
|
Andet: Control
These participants will receive a Fitbit Flex and told to continue with their every day activity levels for a period of 2-6 weeks prior to surgery
|
Each participant will receive a Fitbit.
The Prehabilitaiton Group will receive a Fitbit Charge 2 and they will be able to review their progress on this and be required to increase their exercise activity and input information and data about the exercise they have completed each day during their participation in the study.
The Control group will receive a Fitbit Flex and will not be required to review any of their activity or input any data and will be encouraged to continue with their daily activity rates i.e. not to change.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Quantitative data collected via a Fitbit
Tidsramme: Each participant will be monitored for a period of 2-6 weeks pre surgery
|
Data will be collected to determine the number of participants whose physical activity increased and by how much during the study
|
Each participant will be monitored for a period of 2-6 weeks pre surgery
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Qualitative data collected by questionnaire
Tidsramme: Each participant will be monitored for a period of 2-6 weeks pre surgery
|
Qualitative data will be collected from participants to identify their experience of the study
|
Each participant will be monitored for a period of 2-6 weeks pre surgery
|
|
Quantitative data associated with participants weight at the start and end of the research intervention
Tidsramme: Each participant will be monitored for a period of 2-6 weeks pre surgery
|
Participants weight will be measured in kilograms at the start of their participation and then prior to surgery to determine if they were able to either maintain their weight or gain weight
|
Each participant will be monitored for a period of 2-6 weeks pre surgery
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Omer Aziz, The Christie NHS Foundation Trust
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
14. maj 2019
Primær færdiggørelse (Forventet)
28. december 2019
Studieafslutning (Forventet)
28. december 2019
Datoer for studieregistrering
Først indsendt
15. juli 2019
Først indsendt, der opfyldte QC-kriterier
5. august 2019
Først opslået (Faktiske)
6. august 2019
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
20. august 2019
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
16. august 2019
Sidst verificeret
1. august 2019
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- 19_SURG_19
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
IPD-planbeskrivelse
Data will not currently be shared with researchers outside of the study team
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Indledende studier
-
Vernalis (R&D) LtdAfsluttetFørst i Man StudyDet Forenede Kongerige
-
Ming ZhongRekrutteringARDS (Acute Respiratory Distress Syndrome) | Real World StudyKina
-
Virginia Polytechnic Institute and State UniversityRekrutteringRELAX Telehealth Intervention | Psykoedukativ ventelistekontrol | EMI Smartphone App PilotForenede Stater
-
Antalya Training and Research HospitalHoffmann-La RocheRekrutteringNSCLC trin IV | PD-L1 genmutation | Real World Study | AtezolizumabTyrkiet (Türkiye)
-
Beijing Anzhen HospitalBeijing Life oasis public service centerAfsluttetHjertekrampe | Real World StudyKina
-
Tianjin Medical University Cancer Institute and...Ikke rekrutterer endnuHepatocellulært karcinom (HCC) | Real World Study
-
Royal Cornwall Hospitals TrustAfsluttetFocus Group Study of UK Nursing and Midwifery Council Registrant Nursing Associates, der arbejder inden for mental sundhed, indlæringsvanskeligheder og autisme -tjenesterDet Forenede Kongerige
-
Sichuan Cancer Hospital and Research InstituteRekrutteringALK-positiv ikke-småcellet lungekræft | Real World StudyKina
-
King Abdulaziz UniversityRekrutteringTemporomandibulære lidelser (TMD) | TMJ smerte | Kunstterapi | TMJ - Oral & Maxillofacial Surgery | Wilkes 1 og 2 | TMD Art Pain StudySaudi Arabien
-
Peking University Third HospitalRekrutteringObservationsstudie | Prognose | Nyrecellekarcinom (RCC) | Tumor trombe | Real World Study | Prognostisk kræftmodel | Nyrecellekarcinom (nyrekræft)Kina
Kliniske forsøg med Monitoring using a FitBit
-
Weill Medical College of Cornell UniversityWeill Cornell Medical College in QatarTrukket tilbage
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)AfsluttetKemoterapi-induceret perifer neuropati | Ondartet neoplasmaForenede Stater